Последние новости
BEST for INTRODUCTORY OFFER
。搜狗输入法2026是该领域的重要参考
FoundersUmur Cubukcu FounderUmur Cubukcu FounderOzgun Erdogan FounderOzgun Erdogan FounderDaniel Farina FounderDaniel Farina FounderSimilar JobsSilimateEDA QA/Testing InternSampleFounding Forward Deployed EngineerHadriusFounding Tech Lead & ManagerBerryFounding Full Stack Engineer - LLM, Applied AI (no prior LLM experience required)EkhoFull-stack EngineerBroccoli AIStaff Software Engineer NimbleRxSenior Fullstack EngineerRentHopTaipei Full Stack PHP Developer1stCollabSenior Full-Stack EngineerPeppr AIFrontend/Full-Stack EngineerSyntraForward Deployed EngineerLiveFlowSenior Full Stack EngineerLeadbayEngineering InternNozomioFounding EngineerMediSearchFounding Growth EngineerDreamWorldUnreal Engine Game Developer (Senior+)AtlasSoftware EngineerSplash Inc.Full Stack Software EngineerBesimple AIFounding Engineer (Full-Stack)Cuckoo LabsFull Stack Engineering Internship (Summer 2026)FooterY CombinatorMake something people want.ProgramsYC ProgramStartup SchoolWork at a StartupCo-Founder MatchingResourcesStartup DirectoryStartup LibraryInvestorsDemo DaySafeHacker NewsLaunch YCYC DealsCompanyYC BlogContactPressPeopleCareersPrivacy PolicyNotice at CollectionSecurityTerms of UseTwitterTwitterFacebookFacebookInstagramInstagramLinkedInLinkedInYoutubeYouTube© 2026 Y Combinator
除了小分子抑制剂，核酸技术也开始在ACH治疗中得到应用。Ribomic开发的RBM-007，通过限制FGF2和FGFR3激活变体之间的过度相互作用发挥功能。2期临床结果显示，RBM-007的疗效与Vosoritide相近（1.5厘米/年），甚至有一名受试者年增长5厘米，且该试验中包括2周一次的注射频率，是当前在研药物中最长的给药间隔。